Phibro Animal Health (PAHC) Cash Flow: Operating & Free Cash Flow

Phibro Animal Health Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Phibro Animal Health Corporation (PAHC) - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Jun 2026	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Jun 2019	Jun 2018	Jun 2017
Operating Activities
Net Income	0.00	48.26	2.42	32.61	49.18	54.39	33.55	54.71	64.88	64.62
Depreciation & Amortization	0.00	45.61	36.18	34.01	32.71	31.89	32.34	27.56	26.94	26.00
Deferred Income Tax	0.00	-4.88	-7.84	-2.84	-0.81	-2.18	8.13	-0.11	6.39	-0.03
Stock Based Compensation	0.00	0.72	0.48	0.00	0.00	1.13	2.26	2.26	0.33	0.00
Change in Working Capital	-95.10	-21.56	33.11	-41.13	-44.64	-29.87	-13.66	-35.94	-33.88	1.40
Change in Accounts Receivable	-7.49	-55.21	-8.68	5.34	-23.63	-18.21	28.71	-23.68	-11.90	-2.77
Change in Inventory	-86.34	-44.29	2.64	-11.22	-47.00	-12.50	-12.93	-20.98	-24.29	5.43
Change in Accounts Payable	-12.46	45.56	12.00	-22.83	26.36	3.18	-7.67	12.09	2.45	-3.12
Change in Other Working Capital	11.20	6.05	14.96	-12.42	-0.37	-3.53	-21.77	-3.37	-0.13	1.85
Other Operating Activities	164.05	6.05	15.41	-9.34	-4.79	-9.22	-3.27	-1.32	6.31	127.70
Net Cash from Operating Activities	68.95	80.12	87.59	13.31	31.65	48.31	59.35	47.17	70.01	98.40
Investing Activities
Capital Expenditures	-59.09	-38.29	-41.24	-51.79	-37.04	-29.32	-34.05	-29.89	-18.55	-20.90
Acquisitions	0.00	-286.53	-3.28	0.00	-13.51	29.32	-54.55	-9.84	-15.00	0.00
Purchases of Investments	0.00	-14.00	-65.52	-40.00	-64.10	-74.00	-80.00	-34.00	-82.00	0.00
Sales/Maturities of Investments	0.00	49.00	61.52	17.00	91.45	86.00	49.00	60.00	32.00	0.00
Other Investing Activities	-71.46	1.13	0.33	0.78	0.62	-1.26	-0.80	-0.40	-1.06	-1.00
Net Cash from Investing Activities	-71.46	-288.69	-48.19	-74.02	-22.58	-18.58	-120.39	-14.13	-84.61	-21.90
Financing Activities
Debt Repayment	12.18	-946.01	-22.30	42.69	40.63	-220.63	60.35	13.35	-1.40	-39.53
Common Stock Issued	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.13	5.70	5.54
Dividends Paid	-19.46	-19.45	-19.44	-19.44	-19.44	-19.43	-19.42	-18.59	-16.07	-15.83
Other Financing Activities	0.72	-9.40	-0.03	3.74	-4.84	-2.94	0.00	0.00	0.00	-3.93
Net Cash from Financing Activities	-6.56	207.13	-6.77	26.99	16.34	-17.00	40.94	-4.11	-11.78	-53.74
Summary
Effect of Forex Changes on Cash	2.44	-1.14	-3.30	0.75	-1.37	1.14	-1.12	-0.52	-0.54	-0.23
Net Change in Cash	-6.62	-2.57	29.33	-32.97	24.04	13.87	-21.23	28.41	-26.92	22.48
Cash at Beginning of Period	68.04	70.61	41.28	74.25	50.21	36.34	57.57	29.17	56.08	33.61
Cash at End of Period	61.42	68.04	70.61	41.28	74.25	50.21	36.34	57.57	29.17	56.08
Free Cash Flow	9.87	41.83	46.36	-38.48	-5.40	18.99	25.30	17.28	51.46	77.50
Supplemental Disclosures
Income Taxes Paid	-	13.40	15.43	20.41	17.85	19.40	-	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Phibro Animal Health Cash Flow

What is Phibro Animal Health's free cash flow?

Phibro Animal Health generated free cash flow of $9.87M in fiscal 2026 (fiscal year ended Jun 30, 2026), operating cash flow of $68.95M minus $59.09M of capital expenditures. That was down 76.4% from $41.83M a year earlier. Free cash flow equaled 0.6% of revenue.

How much does Phibro Animal Health spend on capital expenditures?

Phibro Animal Health spent $59.09M on capital expenditures in fiscal 2026, compared with $38.29M a year earlier. That equals 85.7% of operating cash flow.

Does Phibro Animal Health pay dividends or buy back shares?

Yes. In fiscal 2026 Phibro Animal Health returned $19.46M in dividends to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition